Status:
COMPLETED
Triamcinolone Levels in Cochlear Perilymph
Lead Sponsor:
Christoph Arnoldner
Conditions:
Cochlear Hearing Loss
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
Brief Summary
In this study Triamcinolone acetonide will be applied intratympanically before cochlear implant surgery. After round window exposure, a perilymph sample and simultaneously a blood sample will be drawn...
Detailed Description
At the ENT department of the university hospital Vienna (AKH Wien) patients are treated with intratympanic triamcinolone acetonide before cochlea implantation to reduce inflammation and in some cases ...
Eligibility Criteria
Inclusion
- Patients between 18 and 90 years will be included in the study, who will undergo a cochlear implantation and are willing to participate in the study
Exclusion
- Patients younger than 18 years
- Patients who receive cortisone on a regular basis or receive cortisone i.v. or p.o. preoperatively
- Patients with contraindications against the administration of Volon A
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03248856
Start Date
October 2 2017
End Date
May 31 2021
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna (AKH)
Vienna, Austria, 1090